HD•November 18, 2026 at 1:15 PM UTCConsumer Discretionary Distribution & Retail

Q3 comps improve but transactions and SRS guidance still lag; WAIT thesis intact with cautious tone

Read source article

What happened

Home Depot's Q3 FY2026 comparable sales rose 2.2%, driven entirely by a higher average ticket, while comparable transactions fell 0.5%, indicating demand remains concentrated among fewer, larger purchases. The professional segment remains a key strategic focus, but management lowered SRS organic growth guidance, and the specialty distribution business continues to dilute consolidated operating margins, now far below historical 15% levels. The quarter's modest improvement is consistent with our WAIT thesis that stabilization is occurring but not yet broad-based, as traffic remains negative and the Pro platform is scaling without yet converting to meaningful profit. Valuation at current levels still embeds steady demand and Pro stability, leaving little margin of safety if margin pressure persists or housing turnover fails to improve. We maintain a WAIT rating, but the evidence increasingly suggests the upside case requires either a clear transaction inflection or a credible path to margin recovery that has not yet materialized.

Implication

The Q3 report supports a cautious stance: while comps improved to +2.2%, the persistent decline in transactions at -0.5% indicates the recovery is uneven and may not be sustainable without a housing turnover rebound. The reduction in SRS growth guidance undermines a key pillar of the bull case, and the structural margin dilution from specialty distribution suggests operating margins may remain well below historical norms for an extended period. At approximately 23x earnings and 15.6x EV/EBITDA with net debt of $64 billion, the stock is not cheap enough to compensate for these execution and macro risks. We recommend maintaining a WAIT rating and would consider buying only on a pullback toward the attractive entry of $305, as defined in our prior analysis, or if upcoming quarters show transactions turning positive alongside expanding Other segment operating income. Conversely, a break below $300 on continued transaction declines or a gross margin miss versus guidance would validate a more bearish scenario, warranting a reduction in position size.

Thesis delta

The core thesis remains WAIT, but the Q3 data and revised SRS guidance reduce the probability of hitting our bull-case implied value of $365. The persistent negative transactions and structural margin pressure from specialty distribution suggest the path to a sustainable re-rating is longer than previously expected. We keep the WAIT rating but now view the risk/reward as slightly less favorable, with a higher hurdle for the bull case to materialize.

Confidence

Medium-High